Clinical Trial Update: Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White Matter Disease [EARLY_Phase 1]

View source ↗

Summary

A single-patient, early-phase 1 treatment trial for Cree Leukoencephalopathy and Vanishing White Matter Disease is active but not recruiting. It is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cree Leukoencephalopathy
• Vanishing White Matter Disease

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Cree Leukoencephalopathy, Vanishing White Matter | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING